Table 2.
Gastrointestinal irAEs | |
---|---|
Clinical features | Acute onset |
Mild to life‐threatening diarrhea, bowel perforation in severe patients | |
Severity of gastrointestinal differs in different ICIs | |
Higher risk in patients with a medical history of inflammatory bowel disease | |
Endoscopic features | Diverse endoscopic manifestations; Rectum often spared; left colon often involved; diffuse lesion or segmental lesions |
Pathological features |
IBD‐like (increased basal plasma cells, crypts and apoptotic bodies are more common) Lymphocytic colitis‐like Celiac disease‐like (mostly seen in upper gastrointestinal tract) GVHD like |
Immune changes | Clear immune pathogenesis |
CD4+ based T lymphocyte proliferation | |
Th1/Th17 upregulation | |
Interaction with intestinal microbiota |
IBD, inflammatory bowel disease; ICIs, immune‐checkpoint inhibitors; GVHD, graft versus host disease.